Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey

Contraception

Volumn 73, Issue 5, 2006, Pages 493-500

  Nappi, Rossella E ^a   Liekens, Goedele ^b   Brandenburg, Ulrike ^c  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b Klinik für Psychatrie und Psychotherapie ^*  (Belgium)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Attitudes; Contraception; Society; Vagina

Indexed keywords

ADULT; ARTICLE; ATTENTION; ATTITUDE; CONTRACEPTION; FEMALE; HEALTH; HEALTH CARE PERSONNEL; HUMAN; INTERVIEW; KNOWLEDGE; NORMAL HUMAN; ONLINE SYSTEM; PERCEPTION; SOCIETY; TABOO; VAGINA;

ADOLESCENT; ADULT; COMMUNICATION; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERNATIONALITY; VAGINA;

EID: 33646028764     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2005.12.007     Document Type: Article

References (20)

1. Blackledge C. The story of V (2003), Phoenix, London 1-8
2. The Association of Reproductive Health Professionals. Vagina dialogues (2004). http://www.arhp.org/vaginadialogues
3. Hafez E.S. The vagina and human reproduction. Am J Obstet Gynecol 129 (1977) 573-584
4. Alexander N.J., Baker E., Kaptein M., Karck U., Miller L., and Zampaglione E. Why consider vaginal drug administration?. Fertil Steril 82 (2004) 1-12
5. Rosenberg MJ, Waugh MS, Burnhill MS. Compliance, counseling and satisfaction with oral contraceptives: a prospective evaluation. Fam Plann Perspect 1998;30:89-92, 104.
6. Rosenberg M., and Waugh M.S. Causes and consequences of oral contraceptive noncompliance. Am J Obstet Gynecol 180 (1999) S276-S279
7. Rosenberg M.J., Waugh M.S., and Meehan T.E. Use and misuse of oral contraceptives: risk indicators for poor pill-taking and discontinuation. Contraception 51 (1995) 283-288
8. Kaunitz A.M. Oral contraceptive estrogen dose considerations. Contraception 58 (1998) 15S-21S
9. Rosenberg M.J., and Waugh M.S. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 179 (1998) 577-582
10. Roumen F.J., Apter D., Mulders T.M., and Dieben T.O. Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol. Hum Reprod 16 (2001) 469-475
11. Dieben T.O., Roumen F.J., and Apter D. Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring. Obstet Gynecol 100 (2002) 585-593
12. Oddsson K., Leifels-Fischer B., Wiel-Masson D., et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial. Hum Reprod 20 (2005) 557-562
13. Novak A., de la Loge C., Abetz L., and van der Meulen E.A. The combined contraceptive vaginal ring, NuvaRing®: an international study of user acceptability. Contraception 67 (2003) 187-194
14. Szarewski A. High acceptability and satisfaction with NuvaRing use. Eur J Contracept Reprod Health Care 7 Suppl 2 (2002) 31-36 [discussion 37-9]
15. Soper D.E. Genitourinary infections and sexually transmitted diseases. In: Berek J. (Ed). Novak's gynecology (2002), Lippincott, William and Wilkins, Philadelphia 453-470
16. Valore E.V., Park C.H., Igreti S.L., and Ganz T. Antimicrobial components of vaginal fluid. Am J Obstet Gynecol 187 (2002) 561-568
17. Zhang J., Thomas A.G., and Leybovich E. Vaginal douching and adverse health effects: a meta-analysis. Am J Public Health 87 (1997) 1207-1211
18. Ness R.B., Hillier S.L., Richter H.E., et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 100 (2002) 765-772
19. Aubeny E., Buhler M., Colau J.C., Vicaut E., Zadikian M., and Childs M. Oral contraception: patterns of non-compliance. The Coraliance study. Eur J Contracept Reprod Health Care 7 (2002) 155-161
20. Bajos N., Leridon H., Goulard H., Oustry P., Job-Spira N., and COCON Group. Contraception: from accessibility to efficiency. Hum Reprod 18 (2003) 994-999